Beijing Yisen Biotechnology Co., Ltd. (hereinafter referred to as "Yisen") is a national high-tech enterprise and Zhongguancun high-tech enterprise with independent foreign trade management rights, integrating R&D, production, sales and technical services. Based on serving the safety and health of the people's livelihood, we specialize in providing customers with products and technical services in the three major fields of animal disease diagnosis, food safety monitoring and in vitro testing. At present, we have passed a series of international and domestic authoritative certificates, such as the GMP certification of veterinary drugs of the Ministry of Agriculture and ISO9001 quality management system certification.As the first batch of "Specialized and Special new" certified production enterprises in Beijing, we are the director unit of China Veterinary Medical Association and the designated patent pilot unit of Beijing Patent Bureau. The company has been committed to the research on the cutting-edge technology of biological diagnostic products. The scientific and technological achievement "Establishment and application of rapid diagnostic technology R&D platform for livestock and poultry diseases" declared by the company together with China Agricultural University and other organizations won the Second Prize of Science and Technology Progress of Beijing Municipal Science and Technology Award!We have applied for dozens of invention patents certificates, utility model patents certificates, Beijing new technology and new product (service) certificates, a series of new veterinary drug registration certificates and veterinary product approval number certificates, etc. We have participated in the formulation of a number of international, industrial and group standards, and declared a number of projects and awards. In recent years, we have been maintaining the leading competitiveness and technical advantages in the industry.Yisen has been adhering to the concept of "leading innovation, serving diagnosis, escorting health". Based on independent research and development innovation, insist on innovation drive, and constantly promote scientific and technological innovation, product innovation. There is a new technology and new product R & D center, with a group of first-class high-quality, highly educated professionals, of which animal medicine, biochemistry, clinical veterinary and other related professional masters and doctors accounted for more than 60%. Researcher Wang Qin is now the chief scientist and deputy general manager of the company. Under her leadership, a number of R&D projects, such as immunology diagnostic platform (chemiluminescence, enzyme-linked ELISA, rapid test card) and molecular diagnostic platform (nucleic acid extraction, fluorescent PCR, lyophilized gene chip), have made significant breakthroughs. Enhance the core competitiveness of diagnostic reagents and escorts high-quality diagnostic products and national purification service work.……